St. Ives

Description

St. Ives Acne Control Apricot Scrub is an emulsion formulated with salicylic acid. This product is designed to assist in the management of acne through its exfoliating properties. The formulation aims to promote clearer skin by removing dead skin cells and unclogging pores.

Uses and Indications

This drug is indicated for the treatment of acne. It helps prevent the formation of new acne pimples and acne blemishes.

Dosage and Administration

Healthcare professionals are advised to dispense the scrub onto their fingertips and massage it onto damp skin. The application should be performed using small circular motions to ensure even distribution. Following the massage, the scrub should be thoroughly rinsed off to achieve optimal results. For best outcomes, it is recommended that this procedure be repeated 3 to 4 times per week.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to instruct patients to avoid contact with the eyes while using this product. Should contact occur, patients should rinse the affected area with water immediately to alleviate any discomfort.

In cases of accidental ingestion, patients must seek emergency medical assistance or contact a Poison Control Center without delay to ensure appropriate care is provided.

Side Effects

Patients using this medication should be aware that it is for external use only. The application of this product may lead to skin irritation and dryness, particularly if used concurrently with another topical acne medication. In such cases, it is advised to limit the use to one topical acne treatment at a time to minimize the risk of irritation.

Additionally, care should be taken to avoid contact with the eyes. If the product inadvertently comes into contact with the eyes, it is recommended to rinse thoroughly with water to alleviate any discomfort.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the topical agents should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended during the use of this product in conjunction with other topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of St. Ives (acne control apricot scrub). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of St. Ives Acne Control Apricot Scrub in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include airway management, monitoring of vital signs, and intravenous fluid administration as necessary. The use of specific antidotes or treatments should be guided by the clinical scenario and the substances involved.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for further guidance on the management of overdose cases. Documentation of the incident and any interventions performed is crucial for ongoing patient care and for reporting purposes.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability while adhering to safety standards. It is essential to store the product at room temperature to maintain its efficacy.

To ensure safety, the product must be kept out of reach of children and is intended for external use only. After opening, the product should be discarded to prevent any potential contamination or degradation.

Additional Clinical Information

The product is administered topically and is recommended for use 3-4 times a week to achieve optimal results. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for St. Ives, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)